Sunbird Bio

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a diagnostics platform designed to provide fast and accurate results in molecular diagnostics. Sunbird Bio is based in Cambridge, MA and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $27.3 million across 1 recorded round; the latest was a $23.2 million early-stage round in Apr 2023.

Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
Early Stage VC
Apr 2023
Cap table — not yet on record

Sunbird Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Sunbird Bio with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Sunbird Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Sunbird Bio

Where does Sunbird Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Sunbird Bio's 1 recorded funding rounds.